Selected article for: "advanced age and distress syndrome"

Author: Papadopoulos, Vassilios; Li, Lu; Samplaski, Mary
Title: Why does COVID‐19 kill more elderly men than women? Is there a role for testosterone?
  • Cord-id: 192ngdg6
  • Document date: 2020_7_18
  • ID: 192ngdg6
    Snippet: BACKGROUND: Recent epidemiological data indicate that there may be a gender predisposition to COVID‐19, with men predisposed to being most severely affected, and older men accounting for most deaths. OBJECTIVES: Provide a review of the research literature, propose hypotheses and therapies based on the potential link between testosterone (T) and COVID‐19 induced mortality in elderly men. MATERIALS AND METHODS: A search of publications in academic electronic databases, and government and publi
    Document: BACKGROUND: Recent epidemiological data indicate that there may be a gender predisposition to COVID‐19, with men predisposed to being most severely affected, and older men accounting for most deaths. OBJECTIVES: Provide a review of the research literature, propose hypotheses and therapies based on the potential link between testosterone (T) and COVID‐19 induced mortality in elderly men. MATERIALS AND METHODS: A search of publications in academic electronic databases, and government and public health organization web sites on T, aging, inflammation, severe acute respiratory syndrome (SARS) due to coronavirus (CoV) 2 (SARS‐CoV‐2) infection, and COVID‐19 disease state and outcomes was performed. RESULTS: The link between T, the immune system and male aging is well‐established, as is the progressive decline in T levels with aging. In women, T levels drop before menopause and variably increase with advanced age. Elevated IL‐6 is a characteristic biomarker of patients infected with COVID‐19 and has been linked to the development of the acute respiratory distress syndrome (ARDS). Thus far, half of the admitted COVID‐19 patients developed ARDS, half of these patients died, and elderly male patients have been more likely to develop ARDS and die. Low T is associated with ARDS. These data suggest that low T levels may exacerbate the severity of COVID‐19 infection in elderly men. It may also stand to reason that normal T levels may offer some protection against COVID‐19. SARS‐CoV‐2 binds to the angiotensin‐converting enzyme 2, present in high levels in the testis. CONCLUSION: At present, it is not known whether low T levels in aging hypogonadal males create a permissive environment for severe responses to COVID‐19 infection or if the virus inhibits androgen formation. Given the preponderance of COVID‐19 related mortality in elderly males, additional testing for gonadal function and treatment with T may be merited.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute ards respiratory distress syndrome and adaptive innate immune cell: 1, 2
    • acute ards respiratory distress syndrome and additional testing: 1, 2
    • acute ards respiratory distress syndrome and admit patient: 1
    • acute ards respiratory distress syndrome and long short: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and long short term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and long term treatment: 1, 2
    • acute illness and adaptive innate: 1, 2, 3, 4, 5, 6, 7
    • acute illness and additional testing: 1, 2, 3, 4, 5, 6
    • acute illness and long short: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute illness and long short term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute illness and long term treatment: 1, 2, 3, 4, 5
    • acute phase and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute phase and additional testing: 1
    • acute phase and long short: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute phase and long short term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute phase and long term treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and adaptive innate immune cell: 1, 2, 3, 4, 5, 6, 7